Scholars Central

Conference abstractPublished 21 Nov 2016

Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin

Authors: Thanos Mitrelias, Valerii Orel, Anatoliy Shevchenko, Andriy Romanov, Marina Tselepi, Crispin H W Barnes, Anatoliy Burlaka, Sergey Lukin, Igor Shchepotin

University of Cambridge, UK Cavendish NanoTherapeutics Ltd, UK National Cancer Institute, Ukraine G V Kurdyumov Institute for Metal Physics, Ukraine R E Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Ukraine University of Ioannina, Greece

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We will be presenting preliminary clinical data demonstrating the effectiveness of our approach in anti cancer treatment. Our protocols are based on electromagnetic irradiation and on magnetic nanotechnology. Our protocols are given as complementary treatment methods and also have the potential to be used as a substitute of chemotherapy. Our data from human studies demonstrate that our protocol can increase the efficacy of chemotherapy by 15% to 20% (mainly for breast cancer patients). The protocol is based on electromagnetic irradiation that induces mild hyperthermia and increases free radical activity. We also present a second generation technology based on magnetic nanocomplexes comprised of magnetic nanoparticles and anticancer drugs such as doxorubicin. We also present a technology and magneto-mechanical milling chamber for the magneto-mechano-chemical synthesis (MMCS) of magnetosensitive complex nanoparticles (MNC) comprising nanoparticles Fe3O4 and anticancer drug doxorubicin (DOXO). Magnetic properties of MNC were studied with vibrating magnetometer and electron paramagnetic resonance. Under the influence of mechano-chemical and MMCS, the complex showed hysteresis curve, which is typical for soft ferromagnetic materials. Combined action of constant magnetic fieldand radio frequency moderate inductive hyperthermia (RFH) below 40 Ã?°C and MNC was found to induce greater antitumor and anti-metastatic effects as compared to conventional DOXO.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Thanos Mitrelias”
  • BylineArticles whose byline prints “Valerii Orel”
  • BylineArticles whose byline prints “Anatoliy Shevchenko”
  • BylineArticles whose byline prints “Andriy Romanov”
  • BylineArticles whose byline prints “Marina Tselepi”
  • BylineArticles whose byline prints “Crispin H W Barnes”
  • BylineArticles whose byline prints “Anatoliy Burlaka”
  • BylineArticles whose byline prints “Sergey Lukin”